Prognostic value of ISG15 mRNA level in drinkers with esophageal squamous cell cancers

International Journal of Clinical and Experimental Pathology

Volumn 8, Issue 9, 2015, Pages 10975-10984

  Tao, Jun ^a   Hua, Ping ^a   Wen, Jing ^b   Hu, Yi ^b   Yang, Hong ^b   Xie, Xuan ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

Esophageal squamous cell cancers; Ever drinkers; ISG15; MRNA; Prognostic factor

Indexed keywords

CYTOKINE; ISG15 PROTEIN, HUMAN; MESSENGER RNA; TUMOR MARKER; UBIQUITIN;

ADULT; ADVERSE EFFECTS; AGED; AREA UNDER THE CURVE; BIOSYNTHESIS; DRINKING BEHAVIOR; ESOPHAGUS TUMOR; FEMALE; GENE EXPRESSION REGULATION; HUMAN; KAPLAN MEIER METHOD; MALE; METABOLISM; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; REAL TIME POLYMERASE CHAIN REACTION; RECEIVER OPERATING CHARACTERISTIC; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; ALCOHOL DRINKING; AREA UNDER CURVE; BIOMARKERS, TUMOR; CARCINOMA, SQUAMOUS CELL; CYTOKINES; ESOPHAGEAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; ROC CURVE; UBIQUITINS;

EID: 85013018709     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015; 136: E359-386.
2. Brown LM, Devesa SS and Chow WH. Incidence of adenocarcinoma of the esophagus among white Americans by sex, stage, and age. J Natl Cancer Inst 2008; 100: 1184-1187.
3. Lin Y, Totsuka Y, He Y, Kikuchi S, Qiao Y, Ueda J, Wei W, Inoue M and Tanaka H. Epidemiology of esophageal cancer in Japan and China. J Epidemiol 2013; 23: 233-242.
4. Enzinger PC and Mayer RJ. Esophageal cancer. N Engl J Med 2003; 349: 2241-2252.
5. Yang CX, Wang HY, Wang ZM, Du HZ, Tao DM, Mu XY, Chen HG, Lei Y, Matsuo K and Tajima K. Risk factors for esophageal cancer: a case-control study in South-western China. Asian Pac J Cancer Prev 2005; 6: 48-53.
6. Nakachi K, Imai K, Hoshiyama Y and Sasaba T. The joint effects of two factors in the aetiology of oesophageal cancer in Japan. J Epidemiol Community Health 1988; 42: 355-364.
7. Hanaoka T, Tsugane S, Ando N, Ishida K, Kakegawa T, Isono K, Takiyama W, Takagi I, Ide H, Watanabe H, et al. Alcohol consumption and risk of esophageal cancer in Japan: a case-control study in seven hospitals. Jpn J Clin Oncol 1994; 24: 241-246.
8. Wu AH, Wan P and Bernstein L. A multiethnic population-based study of smoking, alcohol and body size and risk of adenocarcinomas of the stomach and esophagus (United States). Cancer Causes Control 2001; 12: 721-732.
9. Brown LM, Hoover R, Silverman D, Baris D, Hayes R, Swanson GM, Schoenberg J, Greenberg R, Liff J, Schwartz A, Dosemeci M, Pottern L and Fraumeni JF Jr. Excess incidence of squamous cell esophageal cancer among US Black men: role of social class and other risk factors. Am J Epidemiol 2001; 153: 114-122.
10. Huang Q, Luo K, Yang H, Wen J, Zhang S, Li J, Ela Bella A, Liu Q, Yang F, Zheng Y, Hu R, Chen J and Fu J. Impact of alcohol consumption on survival in patients with esophageal carcinoma: a large cohort with long-term follow-up. Cancer Sci 2014; 105: 1638-1646.
11. Jeon YJ, Yoo HM and Chung CH. ISG15 and immune diseases. Biochim Biophys Acta 2010; 1802: 485-496.
12. Dao CT and Zhang DE. ISG15: a ubiquitin-like enigma. Front Biosci 2005; 10: 2701-2722.
13. Andersen JB and Hassel BA. The interferon regulated ubiquitin-like protein, ISG15, in tumorigenesis: friend or foe? Cytokine Growth Factor Rev 2006; 17: 411-421.
14. Haas AL, Ahrens P, Bright PM and Ankel H. Interferon induces a 15-kilodalton protein exhibiting marked homology to ubiquitin. J Biol Chem 1987; 262: 11315-11323.
15. Farrell PJ, Broeze RJ and Lengyel P. Accumulation of an mRNA and protein in interferon-treated Ehrlich ascites tumour cells. Nature 1979; 279: 523-525.
16. Chawla-Sarkar M, Lindner DJ, Liu YF, Williams BR, Sen GC, Silverman RH and Borden EC. Apoptosis and interferons: role of interferon-stimulated genes as mediators of apoptosis. Apoptosis 2003; 8: 237-249.
17. Biron CA. Interferons alpha and beta as immune regulators a new look. Immunity 2001; 14: 661-664.
18. Satake H, Tamura K, Furihata M, Anchi T, Sakoda H, Kawada C, Iiyama T, Ashida S and Shuin T. The ubiquitin-like molecule interferon-stimulated gene 15 is overexpressed in human prostate cancer. Oncol Rep 2010; 23: 11-16.
19. Bektas N, Noetzel E, Veeck J, Press MF, Kristiansen G, Naami A, Hartmann A, Dimmler A, Beckmann MW, Knuchel R, Fasching PA and Dahl E. The ubiquitin-like molecule interferon-stimulated gene 15 (ISG15) is a potential prognostic marker in human breast cancer. Breast Cancer Res 2008; 10: R58.
20. Andersen JB, Aaboe M, Borden EC, Goloubeva OG, Hassel BA and Orntoft TF. Stage-associated overexpression of the ubiquitin-like protein, ISG15, in bladder cancer. Br J Cancer 2006; 94: 1465-1471.
21. Rice TW, Rusch VW, Ishwaran H and Blackstone EH. Cancer of the esophagus and esophagogastric junction: data-driven staging for the seventh edition of the American Joint Committee on Cancer/International Union Against Cancer Cancer Staging Manuals. Cancer 2010; 116: 3763-3773.
22. Suzuki T, Urano T, Tsukui T, Horie-Inoue K, Moriya T, Ishida T, Muramatsu M, Ouchi Y, Sasano H and Inoue S. Estrogen-responsive finger protein as a new potential biomarker for breast cancer. Clin Cancer Res 2005; 11: 6148-6154.
23. Nakayama H, Sano T, Motegi A, Oyama T and Nakajima T. Increasing 14-3-3 sigma expression with declining estrogen receptor alpha and estrogen-responsive finger protein expression defines malignant progression of endometrial carcinoma. Pathol Int 2005; 55: 707-715.
24. Li C, Wang J, Zhang H, Zhu M, Chen F, Hu Y, Liu H and Zhu H. Interferon-stimulated gene 15 (ISG15) is a trigger for tumorigenesis and metastasis of hepatocellular carcinoma. Onco-target 2014; 5: 8429-8441.
25. Marietta C, Thompson LH, Lamerdin JE and Brooks PJ. Acetaldehyde stimulates FANCD2 monoubiquitination, H2AX phosphorylation, and BRCA1 phosphorylation in human cells in vitro: implications for alcohol-related carcinogenesis. Mutat Res 2009; 664: 77-83.
26. Fanelli SL, Maciel ME, Diaz Gomez MI, Delgado de Layno AM, Bietto FM, Castro JA and Castro GD. Further studies on the potential contribution of acetaldehyde accumulation and oxidative stress in rat mammary tissue in the alcohol drinking promotion of breast cancer. J Appl Toxicol 2011; 31: 11-19.
27. Brooks PJ and Theruvathu JA. DNA adducts from acetaldehyde: implications for alcohol-related carcinogenesis. Alcohol 2005; 35: 187-193.
28. Hollstein M, Sidransky D, Vogelstein B and Harris CC. p53 mutations in human cancers. Science 1991; 253: 49-53.
29. Saeki H, Ohno S, Araki K, Egashira A, Kawaguchi H, Ikeda Y, Morita M, Kitamura K and Sugimachi K. Alcohol consumption and cigarette smoking in relation to high frequency of p53 protein accumulation in oesophageal squamous cell carcinoma in the Japanese. Br J Cancer 2000; 82: 1892-1894.
30. Kato H, Yoshikawa M, Miyazaki T, Nakajima M, Fukai Y, Tajima K, Masuda N, Tsukada K, Fukuda T, Nakajima T and Kuwano H. Expression of p53 protein related to smoking and alcoholic beverage drinking habits in patients with esophageal cancers. Cancer Lett 2001; 167: 65-72.
31. Polyak K, Xia Y, Zweier JL, Kinzler KW and Vogelstein B. A model for p53-induced apoptosis. Nature 1997; 389: 300-305.
32. Hummer BT, Li XL and Hassel BA. Role for p53 in gene induction by double-stranded RNA. J Virol 2001; 75: 7774-7777.
33. Allen NE, Beral V, Casabonne D, Kan SW, Reeves GK, Brown A and Green J. Moderate alcohol intake and cancer incidence in women. J Natl Cancer Inst 2009; 101: 296-305.